Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Morgan Stanley downgraded Bloomin' Brands Inc (NASDAQ: BLMN) from Overweight to Equal-weight. The price target for Bloomin Brands has been lowered from $25 to $19. Bloomin Brands shares closed at $16.82 on Wednesday.

Keefe Bruyette & Woods downgraded Walker & Dunlop, Inc. (NYSE: WD) from Outperform to Market Perform. The price target for Walker & Dunlop has been raised from $27 to $32. Walker & Dunlop shares closed at $32.11 on Wednesday.

Analysts at Barclays downgraded BankUnited (NYSE: BKU) from Overweight to Equal-weight. The price target for BankUnited has been raised from $38 to $39. BankUnited shares closed at $38.00 on Wednesday.

FBR Capital downgraded Oracle Corporation (NYSE: ORCL) from Outperform to Market Perform. The price target for Oracle is set to $44. Oracle shares closed at $40.49 on Wednesday.

Analysts at FBR Capital downgraded FireEye Inc (NASDAQ: FEYE) from Outperform to Market Perform. The price target for FireEye has been lowered from $53 to $28. FireEye shares closed at $29.12 on Wednesday.

JP Morgan downgraded AVG Technologies NV (NYSE: AVG) from Overweight to Neutral. AVG shares closed at $24.11 on Wednesday.

Analysts at Wells Fargo downgraded Time Warner Inc (NYSE: TWX) from Outperform to Market Perform. Time Warner shares closed at $72.25 on Wednesday.

Stifel Nicolaus downgraded King Digital Entertainment PLC (NYSE: KING) from Buy to Hold. King Digital shares closed at $17.77 on Wednesday.

Analysts at UBS downgraded Avon Products, Inc. (NYSE: AVP) from Neutral to Sell. Avon Products shares closed at $3.44 on Wednesday.

Analysts at JMP Securities downgraded Walker & Dunlop, Inc. (NYSE: WD) from Market Outperform to Market Perform. Walker & Dunlop shares closed at $32.11 on Wednesday.

Latest Ratings for BLMN

DateFirmActionFromTo
Feb 2019UpgradesMarket PerformOutperform
Feb 2019DowngradesUnderperformNeutral
Jan 2019UpgradesNeutralOverweight

View More Analyst Ratings for BLMN
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AVP + AVG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BIDUMaintains147.0
PINSMaintains23.0
GRUBInitiates Coverage On
HOTHInitiates Coverage On
NDRAInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Additional Phase 3 Data Supporting OPKO's Rayaldee as a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at Kidney Week 2015

Argus Upgrades Gannett To Buy, Sees 25% Upside